Pharmacokinetic Characterization of a Prototype Mini Nicotine Lozenge

ConclusionThe prototype mini lozenge is bioequivalent to a commercially available mini lozenge and may provide smokers with a new oral NRT option to aid in smoking cessation and of tobacco dependence through the relief of nicotine withdrawal symptoms, including cravings.

http://link.springer.com/10.1007/s12325-021-01798-4

Source: Advances in Therapy - June 9, 2021 Category: Drugs & Pharmacology Source Type: research